Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision indicator has been updated to a newer site/software version (from v3.5.2 to v3.5.3), without changing the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:53.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:27.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:12:19.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a background site maintenance update and does not modify study content.
    Difference
    0.1%
    Check dated 2026-03-12T01:45:56.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the older maintenance notices (including Revision: v3.4.1) as part of a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:30:26.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    A government funding lapse notice banner was added and the site revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:38:11.000Z thumbnail image

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.